Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026

Insmed (Nasdaq: INSM) will release fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026.

Rhea-AI Summary

Insmed (Nasdaq: INSM) will release fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026. Management will host a conference call at 8:00 a.m. ET that day to discuss results and provide a business update.

Investors may dial domestic and international numbers with access code 7862189, or join a live webcast at www.insmed.com. A replay will be available by phone through February 26, 2026, and the webcast archive will remain on the investor site for 90 days.

Argus Feb 5 session

-0.92% close to close Open Argus

Details

News Market Reaction – INSM

On Feb 5, the day this news came out, INSM closed 0.92% below the previous close.

Data tracked by StockTitan Argus for the Feb 5 session.

Key Figures

Results date: February 19, 2026 Call time: 8:00 a.m. ET Replay end date: February 26, 2026 +5 more

Results date

February 19, 2026

Fourth-quarter and full-year 2025 release date

Call time

8:00 a.m. ET

Start time for the earnings conference call

Replay end date

February 26, 2026

Phone replay availability through this date

Webcast archive

90 days

Duration the webcast will remain available online

Current price

$152.44

Price before this announcement

1-day move

-3%

Price change in the prior 24 hours

52-week high

$212.75

Pre-news 52-week high level

52-week low

$60.40

Pre-news 52-week low level

Previous Conferences,earnings Reports

5 past events · Latest: Oct 15

Same Type 5 events

1. Oct 15

   Q3 2025 call notice

   24h Move

   +1.3%

   Scheduled Q3 2025 earnings release and investor call with webcast details.

2. Jul 24

   Q2 2025 call notice

   24h Move

   +0.1%

   Announced Q2 2025 results date and 8:00 a.m. ET conference call logistics.

3. Apr 23

   Q1 2025 call notice

   24h Move

   -0.6%

   Outlined Q1 2025 release timing and investor call access information.

4. Feb 10

   FY 2024 call notice

   24h Move

   -2.3%

   Set date for Q4 and full-year 2024 results and accompanying business update call.

5. Oct 17

   Q3 2024 call notice

   24h Move

   -3.1%

   Announced Q3 2024 results release and investor conference call schedule.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., Feb. 5, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, February 19, 2026, to discuss financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through February 26, 2026, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two therapies approved to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-fourth-quarter-and-full-year-2025-financial-results-conference-call-on-thursday-february-19-2026-302679597.html

SOURCE Insmed Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Insmed (INSM) report fourth-quarter and full-year 2025 results?

Insmed will release fourth-quarter and full-year 2025 results on Thursday, February 19, 2026. According to the company, management will discuss results on a conference call beginning at 8:00 a.m. ET the same day and provide a business update.

How can investors join the Insmed (INSM) earnings call on February 19, 2026?

Investors can join by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) and using access code 7862189. According to the company, a live webcast will also stream at www.insmed.com for remote participants.

Will Insmed (INSM) provide a webcast and replay of the February 19, 2026 call?

Yes. The call will be webcast live at www.insmed.com, and a replay will be available by phone through February 26, 2026. According to the company, the webcast archive will be posted in the Investor Relations section for 90 days.

What access code is required for the Insmed (INSM) earnings call and replay?

The access code for both the live call and replay is 7862189. According to the company, participants should reference this code when dialing the domestic or international conference and when accessing the replay by phone.

Where will Insmed (INSM) archive the February 19, 2026 earnings webcast?

Insmed will archive the webcast under the Investor Relations section at www.insmed.com for 90 days after the call. According to the company, the archived webcast will be available alongside other investor materials from the event.